Dr. med. Christian Öhlschlegel
Osteolytic changes around biodegradable cement restrictors in hip surgery
Erschbamer M, Zdravkovic V, Erhardt J, Öhlschlegel C, Grob K. Osteolytic changes around biodegradable cement restrictors in hip surgery. Acta Orthop 2016:1-6.
Feb 24, 2016Osteolytic changes around biodegradable cement restrictors in hip surgery
Feb 24, 2016Acta Orthop 2016:1-6
Erschbamer Matthias, Zdravkovic Vilijam, Erhardt Johannes, Öhlschlegel Christian, Grob Karl
Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management
Saladin C, Kubik-Huch R, Stadlmann S, Rageth C, Rageth L, Seifert B, Öhlschlegel C, Kampmann G, Haueisen H. Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management. Acta Radiol 2015; 57:815-21.
Nov 8, 2015Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management
Nov 8, 2015Acta Radiol 2015; 57:815-21
Saladin Camilla, Kubik-Huch Rahel A, Stadlmann S, Rageth Christoph, Rageth Luzi, Seifert B, Öhlschlegel Christian, Kampmann Gert, Haueisen Harald
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials
Regan M, Sessa F, Peg Cámara V, Rodríguez Peralto J, MacGrogan G, Colleoni M, Goldhirsch A, Price K, Coates A, Gelber R, Viale G, Öhlschlegel C, Pizzolitto S, Pagani O, Francis P, Fleming G, Walley B, Kammler R, Dell'Orto P, Russo L, Szőke J, Doimi F, Villani L, SOFT and TEXT Investigators and International Breast Cancer Study Group. Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials. Breast Cancer Res Treat 2015
Oct 22, 2015Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials
Oct 22, 2015Breast Cancer Res Treat 2015
Regan Meredith M, Sessa Fausto, Peg Cámara Vicente, Rodríguez Peralto José Luis, MacGrogan Gaëtan, Colleoni Marco, Goldhirsch Aron, Price Karen N, Coates Alan S, Gelber Richard D, Viale Giuseppe, Öhlschlegel Christian, Pizzolitto Stefano, Pagani Olivia, Francis Prudence A, Fleming Gini F, Walley Barbara A, Kammler Roswitha, Dell'Orto Patrizia, Russo Leila, Szőke János, Doimi Franco, Villani Laura, SOFT and TEXT Investigators and International Breast Cancer Study Group
[Orbital mass in a 23 years old male patient]
Mukherjee R, Öhlschlegel C, Litschel R. [Orbital mass in a 23 years old male patient]. Laryngorhinootologie 2015; 94:690-1.
Aug 6, 2015[Orbital mass in a 23 years old male patient]
Aug 6, 2015Laryngorhinootologie 2015; 94:690-1
Mukherjee Raphael, Öhlschlegel Christian, Litschel Ralph
[My Back is Still Hurting!]
Knechtle B, Jäckel K, Rosemann T, Rüst C, Öhlschlegel C. [My Back is Still Hurting!]. Praxis (Bern 1994) 2015; 104:581-6.
May 20, 2015[My Back is Still Hurting!]
May 20, 2015Praxis (Bern 1994) 2015; 104:581-6
Knechtle Beat, Jäckel Kristian, Rosemann Thomas, Rüst Christoph A, Öhlschlegel Christian
Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study
Varga Z, Cassoly E, Li Q, Öhlschlegel C, Tapia C, Lehr H, Klingbiel D, Thürlimann B, Ruhstaller T. Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study. PloS one 2015; 10:e0123435.
Apr 17, 2015Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study
Apr 17, 2015PloS one 2015; 10:e0123435
Varga Zsuzsanna, Cassoly Estelle, Li Qiyu, Öhlschlegel Christian, Tapia Coya, Lehr Hans Anton, Klingbiel Dirk, Thürlimann Beat, Ruhstaller Thomas
Soft tissue sarcomas of the kidney
Koehle O, Abt D, Rothermundt C, Öhlschlegel C, Brugnolaro C, Schmid H. Soft tissue sarcomas of the kidney. Rare Tumors 2015; 7:5635.
Mar 31, 2015Soft tissue sarcomas of the kidney
Mar 31, 2015Rare Tumors 2015; 7:5635
Koehle Olivia, Abt Dominik, Rothermundt Christian, Öhlschlegel Christian, Brugnolaro C, Schmid Hans-Peter
Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN
Collaud S, Tischler V, Atanassoff A, Wiedl T, Komminoth P, Öhlschlegel C, Weder W, Soltermann A. Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN. BMC cancer 2015; 15:74.
Feb 20, 2015Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN
Feb 20, 2015BMC cancer 2015; 15:74
Collaud Stéphane, Tischler Verena, Atanassoff Andrej, Wiedl Thomas, Komminoth Paul, Öhlschlegel Christian, Weder Walter, Soltermann Alex
Pulmonary embolism in a patient with primary renal synovial sarcoma: the important differential diagnosis of tumor embolism and its therapeutic implications
Schmid S, Öhlschlegel C, Nagel W, Zeisel C, Müller J, Rothermundt C. Pulmonary embolism in a patient with primary renal synovial sarcoma: the important differential diagnosis of tumor embolism and its therapeutic implications. Case Rep Oncol 2013; 6:331-8.
Jun 22, 2013Pulmonary embolism in a patient with primary renal synovial sarcoma: the important differential diagnosis of tumor embolism and its therapeutic implications
Jun 22, 2013Case Rep Oncol 2013; 6:331-8
Schmid Sabine, Öhlschlegel Christian, Nagel Wolfgang, Zeisel Christoph, Müller Joachim, Rothermundt Christian
Comparison of automated and manual FISH for evaluation of HER2 gene status on breast carcinoma core biopsies
Öhlschlegel C, Kradolfer D, Hell M, Jochum W. Comparison of automated and manual FISH for evaluation of HER2 gene status on breast carcinoma core biopsies. BMC Clin Pathol 2013; 13:13.
Apr 20, 2013Comparison of automated and manual FISH for evaluation of HER2 gene status on breast carcinoma core biopsies
Apr 20, 2013BMC Clin Pathol 2013; 13:13
Öhlschlegel Christian, Kradolfer Doris, Hell Margreth, Jochum Wolfram
German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer
AGO, Rageth C, Weber W, Harbeck N, Janni W, Kreipe H, Fitzal F, Resch A, Bago-Horvath Z, Gruber G, Öhlschlegel C, DGS, SGS, ÖGS, Panelists, Executive Board Members, Hoffmann J, Souchon R, Lebeau A, Peintinger F. German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer. Eur J Cancer 2013; 49:2277-83.
Mar 13, 2013German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer
Mar 13, 2013Eur J Cancer 2013; 49:2277-83
AGO, Rageth Christoph, Weber Walter, Harbeck Nadia, Janni Wolfgang, Kreipe Hans, Fitzal Florian, Resch Alexandra, Bago-Horvath Zsuzsanna, Gruber Günther, Öhlschlegel Christian, DGS, SGS, ÖGS, Panelists, Executive Board Members, Hoffmann Jürgen, Souchon Rainer, Lebeau Annette, Peintinger Florentia
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials
Huober J, Regan M, Gelber R, Price K, Öhlschlegel C, Viale G, Coates A, Goldhirsch A, Gelber S, Thürlimann B. Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol 2012; 23:2843-51.
Jun 14, 2012Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials
Jun 14, 2012Ann Oncol 2012; 23:2843-51
Huober Jens, Regan M M, Gelber R D, Price K N, Öhlschlegel Christian, Viale G, Coates A S, Goldhirsch A, Gelber S, Thürlimann Beat
How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists
Varga Z, Viale G, Mastropasqua M, Wagner U, Tapia C, Singer G, Schreiber-Facklam H, Schobinger-Clement S, Sancho Oliver S, Rakozy C, Padberg B, Öhlschlegel C, Obermann E, Noske A, Kaup D, Frick H, Dommann-Scherrer C, Diebold J, Lehr H. How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists. PloS one 2012; 7:e37379.
May 25, 2012How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists
May 25, 2012PloS one 2012; 7:e37379
Varga Zsuzsanna, Viale Giuseppe, Mastropasqua Mauro G, Wagner Urs, Tapia Coya, Singer Gad, Schreiber-Facklam Heide, Schobinger-Clement Sylviane, Sancho Oliver Sara, Rakozy Christiane, Padberg Barbara, Öhlschlegel Christian, Obermann Ellen, Noske Aurelia, Kaup Daniela, Frick Harald, Dommann-Scherrer Corina, Diebold Joachim, Lehr Hans-Anton
Endoscopic treatment of paraesophageal abscess in eosinophilic esophagitis after chest trauma
Sawatzki M, Stienen M, Straumann A, Meyenberger C, Öhlschlegel C, Binek J. Endoscopic treatment of paraesophageal abscess in eosinophilic esophagitis after chest trauma. Gastrointest Endosc 2011
Dec 7, 2011Endoscopic treatment of paraesophageal abscess in eosinophilic esophagitis after chest trauma
Dec 7, 2011Gastrointest Endosc 2011
Sawatzki Mikael, Stienen Martin N., Straumann Alex, Meyenberger Christa, Öhlschlegel Christian, Binek Janek
HER2 genetic heterogeneity in breast carcinoma
Öhlschlegel C, Zahel K, Kradolfer D, Hell M, Jochum W. HER2 genetic heterogeneity in breast carcinoma. J Clin Pathol 2011; 64:1112-6.
Oct 19, 2011HER2 genetic heterogeneity in breast carcinoma
Oct 19, 2011J Clin Pathol 2011; 64:1112-6
Öhlschlegel Christian, Zahel Katharina, Kradolfer Doris, Hell Margreth, Jochum Wolfram
Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer
Varga Z, Moch H, Jochum W, Bosshard G, Kradolfer D, Noske A, Sun Y, Wang Z, Tubbs R, Öhlschlegel C. Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer. Breast Cancer Res Treat 2011
Jun 23, 2011Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer
Jun 23, 2011Breast Cancer Res Treat 2011
Varga Zsuzsanna, Moch Holger, Jochum Wolfram, Bosshard Giovanna, Kradolfer Doris, Noske Aurelia, Sun Yang, Wang Zhen, Tubbs Raymond R, Öhlschlegel Christian
Pseudoangiomatous stromal hyperplasia of breast in man: a case report
Bolla D, Bolla N, Öhlschlegel C, Schoening A, Stickel J, Thürlimann B, Hornung R. Pseudoangiomatous stromal hyperplasia of breast in man: a case report. Breast J 2011; 17:311-2.
May 7, 2011Pseudoangiomatous stromal hyperplasia of breast in man: a case report
May 7, 2011Breast J 2011; 17:311-2
Bolla Daniele, Bolla Nicole, Öhlschlegel Christian, Schoening Andrea, Stickel Juliane, Thürlimann Beat, Hornung René
Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer: a proof-of-concept trial (SAKK 23/03)
Köberle D, Thürlimann B, Pilop C, Crowe S, Öhlschlegel C, von Moos R, Zaman K, Pagani O, Jost L, Ruhstaller T, Swiss Group for Clinical Cancer Research (SAKK). Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer: a proof-of-concept trial (SAKK 23/03). Endocr Relat Cancer 2011; 18:257-64.
Mar 9, 2011Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer: a proof-of-concept trial (SAKK 23/03)
Mar 9, 2011Endocr Relat Cancer 2011; 18:257-64
Köberle Dieter, Thürlimann Beat, Pilop C, Crowe S, Öhlschlegel Christian, von Moos R, Zaman K, Pagani O, Jost L, Ruhstaller Thomas, Swiss Group for Clinical Cancer Research (SAKK)
[Intratumoral heterogeneity of HER2 status in breast carcinoma]
Öhlschlegel C, Zahel K, Kradolfer D, Hell M, Jochum W. [Intratumoral heterogeneity of HER2 status in breast carcinoma]. Pathologe 2010; 31 Suppl 2:292-5.
Oct 1, 2010[Intratumoral heterogeneity of HER2 status in breast carcinoma]
Oct 1, 2010Pathologe 2010; 31 Suppl 2:292-5
Öhlschlegel Christian, Zahel K, Kradolfer D, Hell M, Jochum Wolfram
Sinus Histiocytosis with massive lymphadenopathy (Rosai-Dorfman-disease) treated with Cladribine (2-CdA)
Hengartner H, Öhlschlegel C. Sinus Histiocytosis with massive lymphadenopathy (Rosai-Dorfman-disease) treated with Cladribine (2-CdA). Schweizer Krebsbulletin - Bulletin suisse du cancer 2009; 29:312-314.
Dec 2, 2009Sinus Histiocytosis with massive lymphadenopathy (Rosai-Dorfman-disease) treated with Cladribine (2-CdA)
Dec 2, 2009Schweizer Krebsbulletin - Bulletin suisse du cancer 2009; 29:312-314
Hengartner Heinz, Öhlschlegel Christian